zzzzzzz

Geez discussion of this stock is dead !

In my view CIR is an interesting stock. About 4 years ago I used to be a holder and haven't looked at the company during that time till a few weeks ago.

Sentiment is terrible in the whole biotech sector right now and in the absence of a pick up in the ASX as a whole it may remain that way for quite some time. That said, there maybe some bargains to be had... CIR is trading awfully close to cash backing and is possible entering into bargain territory.

Whilst the clinical trials and other research around Vegenics hold enormous promise into the future, CIR need to get some cash into the company and that will hopefully be in the form of 2 diagnostics due on the market next year. Without a decent contribution from these two CIR will be forced to raise cash in the next 12 month.

I am not yet a holder but will be at around 42 cents.